- Home
- ANVS vs MCHX Comparison
ANVS vs MCHX Comparison
Compare ANVS & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | MCHX |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 71.6M |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ANVS | MCHX |
|---|---|---|
| Price | $3.98 | $1.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 592.2K | 22.3K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $46,494,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $1.26 |
| 52 Week High | $5.57 | $2.31 |
Technical Indicators
Market Signals| Indicator | ANVS | MCHX |
|---|---|---|
| Relative Strength Index (RSI) | 55.18 | 57.75 |
| Support Level | $3.26 | $1.59 |
| Resistance Level | $3.72 | $1.69 |
| Average True Range (ATR) | 0.24 | 0.07 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 78.41 | 81.30 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About MCHX Marchex Inc. Class B
Marchex Inc harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communications channels, enabling enterprise strategies, empowering businesses to increase revenue through informed decision-making and strategic execution.